These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

246 related articles for article (PubMed ID: 30545525)

  • 21. Pharmacogenetics for Safe Codeine Use in Sickle Cell Disease.
    Gammal RS; Crews KR; Haidar CE; Hoffman JM; Baker DK; Barker PJ; Estepp JH; Pei D; Broeckel U; Wang W; Weiss MJ; Relling MV; Hankins J
    Pediatrics; 2016 Jul; 138(1):. PubMed ID: 27335380
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Re: Apnea in a child after oral codeine: a genetic variant - an ultra-rapid metabolizer [corrected].
    de Wildt SN; Koren G
    Paediatr Anaesth; 2008 Mar; 18(3):273-4; author's reply 275-6. PubMed ID: 18230076
    [No Abstract]   [Full Text] [Related]  

  • 23. Assessment of tramadol pharmacokinetics in correlation with CYP2D6 and clinical symptoms.
    Ahmadimanesh M; Naeini MB; Rouini MR; Shadnia S; Ghazi-Khansari M
    Drug Metab Pers Ther; 2020 Jun; 35(2):. PubMed ID: 32681776
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Apnea in a child after oral codeine: a genetic variant - an ultra-rapid metabolizer.
    Voronov P; Przybylo HJ; Jagannathan N
    Paediatr Anaesth; 2007 Jul; 17(7):684-7. PubMed ID: 17564651
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinical perspective on the Clinical Pharmacogenetics Implementation Consortium Updated 2014 guidelines for CYP2D6 and codeine.
    Nicholson WT; Formea CM
    Clin Chem; 2015 Feb; 61(2):319-21. PubMed ID: 25301855
    [No Abstract]   [Full Text] [Related]  

  • 26. Effects of type 1 and type 2 diabetes on the pharmacokinetics of tramadol enantiomers in patients with neuropathic pain phenotyped as cytochrome P450 2D6 extensive metabolizers.
    de Moraes NV; Lauretti GR; Lanchote VL
    J Pharm Pharmacol; 2014 Sep; 66(9):1222-30. PubMed ID: 24717054
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pharmacogenomics: why standard codeine doses can have serious toxicities or no therapeutic effect.
    Kelly PA
    Oncol Nurs Forum; 2013 Jul; 40(4):322-4. PubMed ID: 23803265
    [No Abstract]   [Full Text] [Related]  

  • 28. Quick onset of severe abdominal pain after codeine in an ultrarapid metabolizer of debrisoquine.
    Dalén P; Frengell C; Dahl ML; Sjöqvist F
    Ther Drug Monit; 1997 Oct; 19(5):543-4. PubMed ID: 9357099
    [TBL] [Abstract][Full Text] [Related]  

  • 29. CYP2D6 Basic Genotyping of Patients with Chronic Pain Receiving Tramadol or Codeine. A Study in a Greek Cohort.
    Batistaki C; Chrona E; Kostroglou A; Kostopanagiotou G; Gazouli M
    Pain Med; 2020 Nov; 21(11):3199-3204. PubMed ID: 32443139
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Codeine and opioid metabolism: implications and alternatives for pediatric pain management.
    Chidambaran V; Sadhasivam S; Mahmoud M
    Curr Opin Anaesthesiol; 2017 Jun; 30(3):349-356. PubMed ID: 28323671
    [TBL] [Abstract][Full Text] [Related]  

  • 31. CYP2D6-guided opioid therapy improves pain control in CYP2D6 intermediate and poor metabolizers: a pragmatic clinical trial.
    Smith DM; Weitzel KW; Elsey AR; Langaee T; Gong Y; Wake DT; Duong BQ; Hagen M; Harle CA; Mercado E; Nagoshi Y; Newsom K; Wright A; Rosenberg EI; Starostik P; Clare-Salzler MJ; Schmidt SO; Fillingim RB; Johnson JA; Cavallari LH
    Genet Med; 2019 Aug; 21(8):1842-1850. PubMed ID: 30670877
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Trends in Tramadol: Pharmacology, Metabolism, and Misuse.
    Miotto K; Cho AK; Khalil MA; Blanco K; Sasaki JD; Rawson R
    Anesth Analg; 2017 Jan; 124(1):44-51. PubMed ID: 27861439
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Inhibition of CYP2D6-mediated tramadol O-demethylation in methadone but not buprenorphine maintenance patients.
    Coller JK; Michalakas JR; James HM; Farquharson AL; Colvill J; White JM; Somogyi AA
    Br J Clin Pharmacol; 2012 Nov; 74(5):835-41. PubMed ID: 22369095
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Drug-gene and drug-drug interactions associated with tramadol and codeine therapy in the INGENIOUS trial.
    Fulton CR; Zang Y; Desta Z; Rosenman MB; Holmes AM; Decker BS; Zhang Y; T Callaghan J; Pratt VM; Levy KD; Gufford BT; Dexter PR; Skaar TC; Eadon MT
    Pharmacogenomics; 2019 Apr; 20(6):397-408. PubMed ID: 30784356
    [No Abstract]   [Full Text] [Related]  

  • 35. New FDA black box warning for codeine: how will this affect dentists?
    Weaver JM
    Anesth Prog; 2013; 60(2):35-6. PubMed ID: 23763556
    [No Abstract]   [Full Text] [Related]  

  • 36. CYP2D6 polymorphisms and codeine analgesia in postpartum pain management: a pilot study.
    VanderVaart S; Berger H; Sistonen J; Madadi P; Matok I; Gijsen VM; de Wildt SN; Taddio A; Ross CJ; Carleton BC; Hayden MR; Koren G
    Ther Drug Monit; 2011 Aug; 33(4):425-32. PubMed ID: 21743374
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Suspected opioid overdose case resolved by CYP2D6 genotyping.
    Shaw KD; Amstutz U; Jimenez-Mendez R; Ross CJ; Carleton BC
    Ther Drug Monit; 2012 Apr; 34(2):121-3. PubMed ID: 22406651
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Respiratory arrest precipitated by codeine in a child with chronic renal failure.
    Talbott GA; Lynn AM; Levy FH; Zelikovic I
    Clin Pediatr (Phila); 1997 Mar; 36(3):171-3. PubMed ID: 9078419
    [No Abstract]   [Full Text] [Related]  

  • 39. Differential Consequences of Tramadol in Overdosing: Dilemma of a Polymorphic Cytochrome P450 2D6-Mediated Substrate.
    Srinivas NR
    J Pain Palliat Care Pharmacother; 2015 Sep; 29(3):272-5. PubMed ID: 26367475
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Unexceptional seizure potential of tramadol or its enantiomers or metabolites in mice.
    Raffa RB; Stone DJ
    J Pharmacol Exp Ther; 2008 May; 325(2):500-6. PubMed ID: 18292293
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.